According to Cosmo Pharmaceuticals's latest financial reports the company's total liabilities are HK$1.10 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | HK$1.07 B | -56.49% |
2022-12-31 | HK$2.47 B | -4.15% |
2021-12-31 | HK$2.58 B | 38.37% |
2020-12-31 | HK$1.86 B | 11.92% |
2019-12-31 | HK$1.67 B | 3.09% |
2018-12-31 | HK$1.61 B | 520.34% |
2017-12-31 | HK$0.26 B | 14.69% |
2016-12-31 | HK$0.22 B | -21.66% |
2015-12-31 | HK$0.29 B | -57.99% |
2014-12-31 | HK$0.69 B | 182.72% |
2013-12-31 | HK$0.24 B | -12.4% |
2012-12-31 | HK$0.27 B | 89.63% |
2011-12-31 | HK$0.14 B | -57.47% |
2010-12-31 | HK$0.34 B | 167.18% |
2009-12-31 | HK$0.12 B | -17.41% |
2008-12-31 | HK$0.15 B | 14.12% |
2007-12-31 | HK$0.13 B | -34.86% |
2006-12-31 | HK$0.21 B | -16.65% |
2005-12-31 | HK$0.25 B | -1.28% |
2004-12-31 | HK$0.25 B |